22:29 , May 3, 2018 |  BC Innovations  |  Strategy

Seeking CRISP answers

The ongoing litigation in the U.S. over CRISPR-Cas9 patents could be resolved this year, but it will take longer to get a clear picture of the global CRISPR IP landscape. It is possible that companies...
16:09 , Apr 26, 2018 |  BC Innovations  |  Emerging Company Profile

Mammoth makes Dx CRISPR

Mammoth Biosciences emerged from stealth with an exclusive license to Jennifer Doudna’s CRISPR-based diagnostics technology, which could enable faster diagnosis of a range of diseases than PCR-based sequencing and culture-based techniques and be more adaptable...
23:36 , Mar 29, 2018 |  BC Innovations  |  Tools & Techniques

Cutting-edge diagnostics

Following the splash that CRISPR has made in the world of therapeutics, academics are expanding the tool kit of Cas enzymes and finding new uses in diagnostics. Early hints suggest the technology could become competitive,...
23:49 , Mar 16, 2018 |  BC Extra  |  Preclinical News

New Cas enzyme can edit RNA, target tau

In Cell, researchers from the Salk Institute for Biological Studies discovered a new RNA-targeting CRISPR enzyme, CRISPR-associated protein 13d (Cas13d), and showed it could be used to edit the transcript of a frontotemporal dementia target,...
16:03 , Mar 15, 2018 |  BC Extra  |  Company News

Arbor launches with $15.6 million, new CRISPR enzyme

Arbor Biotechnologies Inc. (Cambridge, Mass.) emerged from stealth mode on Thursday with a study detailing the discovery of a new CRISPR enzyme, CRISPR-associated protein 13d (Cas13d), and a $15.6 million series A round that closed...
18:40 , Jan 18, 2018 |  BC Innovations  |  Translation in Brief

Editing translation

CRISPR pioneer Jennifer Doudna has expanded the technology’s reach to diseases involving RNA targets with a new publication showing at least two of the CRISPR-based systems used to edit nuclear DNA can also bind and...
18:51 , Apr 27, 2017 |  BC Innovations  |  Translation in Brief

A cutting diagnosis

CRISPR pioneer Feng Zhang has expanded the use of the gene editing technology to diagnostics by using an alternative cutting enzyme, and showed it can be used to create a sensitive tool for point-of-care detection...
22:31 , Apr 14, 2017 |  BC Extra  |  Clinical News

Broad team describes CRISPR-based diagnostic tool

In a paper published in Science on Thursday, Feng Zhang and colleagues at the Broad Institute of MIT and Harvard described a new CRISPR-based diagnostic system for rapid point-of-care detection of pathogens such as Zika...